32nd World Congress of the World Society of Cardiovascular and Thoracic Surgeons in Barcelona, 5.-7. September 2024

Dr. Sarikouch is going to present “Long-term results of modern homografts” within the session "Cardiovascular Tissue Banking at the WSCTS in Barcelona, ”. Decellularized pulmonary and aortic homografts have been studied in prospective European-wide multi-center settings.


https://academic.oup.com/ejcts/article/62/5/ezac219/6568944


https://academic.oup.com/ejcts/article/65/4/ezae121/7635581



39th EACTS Annual Meeting, 8-11. October 2025 in Copenhagen/Denmark


20-year data from two European centres for decellularized pulmonary homografts  will be presented at the upcoming annual EACTS meeting in Copenhagen. The abstract will presented within the Ross Session on Thursday 9th of October 2025 at 10.00 am in Auditorium 10.


Programme


Ross-Symposium 2025 in Lübeck/Germany - Role of decellularized pulmonary homografts for paediatric Ross patients

The Ross autograft operation for aortic valve replacement requires pulmonary valve replacement. This is usually performed with a homograft. Dr. Sarikouch from Hannover Medical School presented the current evidence for decellularized pulmonary homografts for pulmonary valve replacement in the Ross operation for adults and children.


https://www.uksh.de/Service/Veranstaltungen+am+UKSH-event-Herzchirurgie_Luebeck.de.4862.html




This project has received funding from the European Union’s Seventh Framework Programme (FP7/2007-20013) under Grant Agreement Number 278453.

ClinicalTrials.gov identifier: NCT02035540